Adenocyte, LLC

Industry · 6 registered clinical trials — 5 currently recruiting.

Status	Trial	Phase	Started
Enrolling By Invitation	The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas) IPMN, Pancreatic, Pancreas Cancer, Pancreatic Cyst	—	2024-10-15
Not Yet Recruiting	The LINFU® U.S. Registry for the in the General Population Without Risk Factors Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Dysplasia	—	2024-09-15
Not Yet Recruiting	The LINFU® U.S. Registry in Patients With Clinical Signs and/or Symptoms of Disease Pancreatic Cancer, Jaundice, Abdominal Neoplasm	—	2024-06-30
Enrolling By Invitation	Evaluating LINFU™: A Noninvasive Method for Collecting Pancreatic Cells for the Early Detection of Pancreatic Pancreatic Ductal Adenocarcinoma	—	2024-01-31
Enrolling By Invitation	The LINFU® U.S. Registry for the Detection of Asymptomatic Pancreatic Ductal Adenocarcinoma Pancreatic Adenocarcinoma, Pancreatic Intraepithelial Neoplasia	—	2024-01-31
Completed	A Proof-of-Concept Study Evaluating LINFU™ Pancreas Adenocarcinoma, Dysplasia	N/A	2021-10-21